CN1753873A - 作为液晶的氰基吡啶酮衍生物 - Google Patents

作为液晶的氰基吡啶酮衍生物 Download PDF

Info

Publication number
CN1753873A
CN1753873A CNA2004800048984A CN200480004898A CN1753873A CN 1753873 A CN1753873 A CN 1753873A CN A2004800048984 A CNA2004800048984 A CN A2004800048984A CN 200480004898 A CN200480004898 A CN 200480004898A CN 1753873 A CN1753873 A CN 1753873A
Authority
CN
China
Prior art keywords
liquid crystal
general formula
cyanopyridone
alkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA2004800048984A
Other languages
English (en)
Chinese (zh)
Inventor
L·D·法兰德
M·赫克梅尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Patent GmbH
Original Assignee
Merck Patent GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent GmbH filed Critical Merck Patent GmbH
Publication of CN1753873A publication Critical patent/CN1753873A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C07D213/85—Nitriles in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00—Liquid crystal materials
    • C09K19/04—Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06—Non-steroidal liquid crystal compounds
    • C09K19/34—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3483—Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a non-aromatic ring
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00—Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C09K2323/02—Alignment layer characterised by chemical composition

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyridine Compounds (AREA)
  • Polarising Elements (AREA)
  • Cosmetics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
CNA2004800048984A 2003-02-22 2004-01-23 作为液晶的氰基吡啶酮衍生物 Pending CN1753873A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03003968 2003-02-22
EP03003968.9 2003-02-22

Publications (1)

Publication Number Publication Date
CN1753873A true CN1753873A (zh) 2006-03-29

Family

ID=32892857

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA2004800048984A Pending CN1753873A (zh) 2003-02-22 2004-01-23 作为液晶的氰基吡啶酮衍生物

Country Status (7)

Country Link
US (1) US7442475B2 (https=)
EP (1) EP1594842A1 (https=)
JP (1) JP2006523184A (https=)
KR (1) KR20050109505A (https=)
CN (1) CN1753873A (https=)
TW (1) TW200504186A (https=)
WO (1) WO2004074253A1 (https=)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107003578A (zh) * 2014-12-19 2017-08-01 默克专利股份有限公司 光调制元件
CN108341771A (zh) * 2017-01-21 2018-07-31 浙江九洲药业股份有限公司 一种3-氰基-2,6-二羟基吡啶钠水合物的制备方法
CN109705343A (zh) * 2018-12-12 2019-05-03 上海交通大学 薁基共价三嗪骨架及其应用
CN112980225A (zh) * 2021-02-25 2021-06-18 张家港莱拓新材料科技有限公司 一种新型可聚合介晶混合物涂料及其应用

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1807085B1 (en) 2004-09-20 2013-08-21 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580762A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AU2005286648A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP2289510A1 (en) 2004-09-20 2011-03-02 Xenon Pharmaceuticals Inc. Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes
CA2580857A1 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
US7829712B2 (en) 2004-09-20 2010-11-09 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-CoA-desaturase
AR051091A1 (es) 2004-09-20 2006-12-20 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
LU91146B1 (en) 2005-03-10 2006-09-11 Ipalco Bv Device for suppying preconditioned air to an aircraft on the ground
AU2006343359A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US8795630B2 (en) * 2008-08-29 2014-08-05 Treventis Corporation Butyrylcholinesterase ligands as diagnostic tools and treatment for diseases of the nervous system
US8257639B2 (en) * 2009-09-22 2012-09-04 Kent State University Method of making stimuli responsive liquid crystal-polymer composite fibers
US8168084B2 (en) 2009-12-18 2012-05-01 Vanderbilt University Polar nematic compounds
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
JP6223563B2 (ja) 2013-10-14 2017-11-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 選択的に置換されたキノリン化合物
CN105636945B (zh) 2013-10-14 2017-11-17 卫材R&D管理有限公司 选择性取代的喹啉化合物
KR102392188B1 (ko) 2014-10-27 2022-04-28 삼성전자주식회사 편광 필름용 조성물, 편광 필름 및 표시 장치
CN113292576B (zh) * 2021-06-08 2023-05-30 山西大学 一类基于三苯胺的光热小分子及其制备方法和应用
KR20240035820A (ko) 2021-07-09 2024-03-18 플렉시움 인코포레이티드 Ikzf2를 조절하는 아릴 화합물 및 약학 조성물

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180188B1 (en) * 1984-10-30 1992-04-15 Otsuka Pharmaceutical Co., Ltd. A composition for increasing the anti-cancer activity of an anti-cancer compound
US4864021A (en) 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
JPH0674248B2 (ja) * 1985-12-20 1994-09-21 チッソ株式会社 含窒素化合物
JPH0625119B2 (ja) * 1985-04-22 1994-04-06 チッソ株式会社 新規ピリジン誘導体
JPS6219568A (ja) * 1985-07-18 1987-01-28 Chisso Corp 新規ピリジン誘導体
JPS61204168A (ja) * 1985-03-06 1986-09-10 Chisso Corp ピリジン誘導体
JPS61233672A (ja) * 1985-04-08 1986-10-17 Chisso Corp 正の誘電異方性を示すピリジン誘導体
US4684477A (en) * 1985-03-06 1987-08-04 Chisso Corporation Pyridine derivatives and their use in liquid crystals
DE3786834T2 (de) * 1986-04-30 1994-03-03 Otsuka Pharma Co Ltd 5-Fluoro-Uracil-Derivate.
JPH0688996B2 (ja) * 1986-07-24 1994-11-09 大塚製薬株式会社 ５−フルオロウラシル誘導体
JPS63201127A (ja) * 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd ５−フルオロウラシル誘導体を含有する制癌剤
JPH0749422B2 (ja) * 1986-12-25 1995-05-31 大塚製薬株式会社 ５−フルオロ−５，６−ジヒドロウラシル誘導体
EP0310676A4 (de) 1987-04-07 1989-04-27 Pavljuchenko Assya I Flüssigkristallderivate von 2,5-disubstituierten pyridinen als komponenten von flüssigkristallmaterialien und flüssigkristallmaterial.
JPH02500274A (ja) * 1987-12-30 1990-02-01 パフルユチェンコ，アススヤ　イオシフォフナ 液晶材料の成分としての２，５‐二置換ピリジンの液晶誘導体および液晶材料
JP2700263B2 (ja) * 1988-12-16 1998-01-19 大塚製薬株式会社 ５―フルオロウラシル誘導体の製造法
JPH04288058A (ja) * 1990-07-11 1992-10-13 Fuji Photo Film Co Ltd フェニルピリジン化合物及びこれを含有する液晶組成物
JPH04217665A (ja) 1990-10-26 1992-08-07 Fuji Photo Film Co Ltd 分岐を有するフェニルピリジン化合物及びこれを含有する液晶組成物
JP3060331B2 (ja) * 1991-07-18 2000-07-10 コニカ株式会社 カラーフィルターアレイ素子
JPH0551536A (ja) * 1991-08-26 1993-03-02 Mitsubishi Kasei Corp パーフルオロアルキル基含有アゾ系色素
US5578419A (en) * 1991-12-12 1996-11-26 Mitsui Toatsu Chemicals, Incorporated Dyes for color filters, and photosensitive resist resin composition containing the same
JPH07207169A (ja) * 1994-01-12 1995-08-08 Mitsui Toatsu Chem Inc 偏光フィルム用アゾ系色素及びこれを用いた偏光フィルム
GB9922136D0 (en) * 1999-09-20 1999-11-17 Avecia Ltd Compounds, compositions and use
US6664025B2 (en) * 2002-02-12 2003-12-16 Kodak Polychrome Graphics Llc Visible radiation sensitive composition

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107003578A (zh) * 2014-12-19 2017-08-01 默克专利股份有限公司 光调制元件
CN108341771A (zh) * 2017-01-21 2018-07-31 浙江九洲药业股份有限公司 一种3-氰基-2,6-二羟基吡啶钠水合物的制备方法
CN108341771B (zh) * 2017-01-21 2021-05-11 浙江九洲药业股份有限公司 一种3-氰基-2,6-二羟基吡啶钠水合物的制备方法
CN109705343A (zh) * 2018-12-12 2019-05-03 上海交通大学 薁基共价三嗪骨架及其应用
CN112980225A (zh) * 2021-02-25 2021-06-18 张家港莱拓新材料科技有限公司 一种新型可聚合介晶混合物涂料及其应用

Also Published As

Publication number Publication date
US20060165916A1 (en) 2006-07-27
WO2004074253A1 (en) 2004-09-02
EP1594842A1 (en) 2005-11-16
TW200504186A (en) 2005-02-01
US7442475B2 (en) 2008-10-28
KR20050109505A (ko) 2005-11-21
JP2006523184A (ja) 2006-10-12

Similar Documents

Publication Publication Date Title
CN1753873A (zh) 作为液晶的氰基吡啶酮衍生物
JP5597141B2 (ja) 反応性メソゲン化合物および混合物
JP5675107B2 (ja) シクロヘキシレン反応性メソゲンおよびそれらの用途
JP5058432B2 (ja) 側位に置換基を有する重合性シンナメート
CN103562347B (zh) 液晶介质和液晶显示器
CN104685025B (zh) 液晶介质和液晶显示器
CN101080480A (zh) 液晶体系和液晶显示器
JP6389509B2 (ja) メソゲン性化合物、液晶媒体および液晶ディスプレイ
CN104254586B (zh) 液晶介质和液晶显示器
CN1820062A (zh) 取代蒽
JP6386378B2 (ja) 液晶媒体および液晶ディスプレイ
KR101333869B1 (ko) 키랄 화합물
JP6266513B2 (ja) 液晶媒体および液晶ディスプレイ
TW200305636A (en) Polymerisable compounds comprising a cinnamic acid group and an acetylene group
KR101442270B1 (ko) 액정 물질로서 사용하기 위한 키랄 바이나프틸 설페이트
KR20080053949A (ko) 키랄 화합물
US20080167482A1 (en) Liquid Crystal Compounds, Liquid Crystal Medium and Liquid Crystal Display
JP4744809B2 (ja) キラルな化合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20060329